Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 13 04:00PM ET
96.00
Dollar change
-1.91
Percentage change
-1.95
%
Index- P/E200.54 EPS (ttm)0.48 Insider Own0.25% Shs Outstand237.73M Perf Week-5.71%
Market Cap22.82B Forward P/E- EPS next Y-2.37 Insider Trans0.00% Shs Float237.14M Perf Month4.03%
Income117.93M PEG- EPS next Q-2.24 Inst Own17.79% Short Float1.28% Perf Quarter3.33%
Sales2.95B P/S7.73 EPS this Y-147.29% Inst Trans12.40% Short Ratio4.15 Perf Half Y-2.69%
Book/sh90.72 P/B1.06 EPS next Y-21.28% ROA0.49% Short Interest3.04M Perf Year-16.96%
Cash/sh40.78 P/C2.35 EPS next 5Y- ROE0.54% 52W Range85.21 - 125.83 Perf YTD-9.04%
Dividend Est.- P/FCF3.95 EPS past 5Y- ROI0.54% 52W High-23.71% Beta0.25
Dividend TTM- Quick Ratio11.16 Sales past 5Y843.27% Gross Margin79.32% 52W Low12.66% ATR (14)3.53
Dividend Ex-DateJun 02, 2022 Current Ratio11.38 EPS Y/Y TTM-98.06% Oper. Margin-13.07% RSI (14)49.05 Volatility2.85% 4.06%
Employees3082 Debt/Eq0.01 Sales Y/Y TTM-76.62% Profit Margin4.00% Recom2.33 Target Price113.44
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q-164.64% Payout0.00% Rel Volume0.51 Prev Close97.91
Sales Surprise-57.48% EPS Surprise-6.12% Sales Q/Q-85.14% EarningsMay 06 BMO Avg Volume732.08K Price96.00
SMA20-1.38% SMA503.75% SMA200-2.70% Trades Volume384,220 Change-1.95%
Date Action Analyst Rating Change Price Target Change
May-14-24Initiated Evercore ISI In-line $100
Feb-23-24Initiated BMO Capital Markets Outperform $127
Jan-05-24Initiated Oppenheimer Perform
Dec-01-23Downgrade JP Morgan Neutral → Underweight $106 → $99
Oct-16-23Downgrade HSBC Securities Buy → Hold $124 → $111
Jul-14-23Initiated HSBC Securities Buy $124
May-17-23Upgrade Redburn Neutral → Buy $165 → $170
Dec-15-22Upgrade BofA Securities Neutral → Buy $239
Aug-17-22Initiated Cowen Market Perform $177
Jul-13-22Upgrade SVB Leerink Mkt Perform → Outperform
Jun-03-24 03:41PM
09:17AM
04:45AM
Jun-01-24 10:00AM
May-31-24 07:15AM
04:25AM Loading…
May-30-24 04:25AM
May-29-24 08:00AM
May-26-24 08:00PM
May-24-24 12:16PM
08:15AM
May-21-24 06:45AM
04:00AM
May-20-24 02:09PM
May-18-24 02:42AM
May-17-24 02:46PM
01:17PM Loading…
01:17PM
12:36PM
11:15AM
May-14-24 07:58AM
May-07-24 11:26AM
06:22AM
05:08AM
May-06-24 04:14PM
04:04PM
02:30PM
12:11PM
12:02PM
11:53AM
10:16AM
08:57AM
08:15AM Loading…
08:15AM
07:31AM
07:23AM
07:03AM
07:03AM
06:49AM
06:45AM
May-03-24 10:08AM
Apr-30-24 11:58AM
Apr-25-24 01:51PM
01:28PM
12:55PM
11:27AM
09:54AM
09:39AM
Apr-23-24 07:21AM
Apr-22-24 06:08PM
06:45AM
Apr-07-24 02:00PM
Mar-31-24 03:39PM
Mar-26-24 09:53AM
06:44AM
01:00AM
Mar-25-24 06:47AM
06:19AM
Mar-21-24 11:38AM
01:43AM
Mar-20-24 04:45PM
03:56PM
03:38PM
02:45PM
11:05AM
10:34AM
09:20AM
09:09AM
07:49AM
06:22AM
06:17AM
06:15AM
06:15AM
06:00AM
Mar-17-24 09:19AM
08:50AM
Mar-15-24 05:53AM
Mar-14-24 01:51PM
Mar-13-24 11:07AM
Mar-11-24 03:29PM
07:45AM
Mar-09-24 01:09PM
Mar-08-24 01:25AM
Mar-07-24 06:45AM
Mar-06-24 04:45PM
06:45AM
Mar-05-24 04:16AM
Mar-04-24 06:42PM
05:33PM
10:06AM
Mar-02-24 10:42AM
Feb-27-24 05:45AM
Feb-26-24 12:29PM
10:27AM
Feb-23-24 01:00PM
Feb-14-24 06:35PM
Feb-08-24 06:07AM
05:45AM
Feb-04-24 06:56AM
Feb-02-24 02:39PM
Feb-01-24 06:30AM
Jan-31-24 06:45AM
Jan-25-24 09:55AM
BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.